Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM).
Batinić J, Dreta B, Rinčić G, Mrdeža A, Jakobac KM, Krišto DR, Vujčić M, Piršić M, Jonjić Ž, Periša V, Sinčić Petričević J, Coha B, Holik H, Valković T, Stanić M, Krečak I, Stojanović A, Sajfert D, Bašić-Kinda S. Batinić J, et al. Among authors: holik h. Medicina (Kaunas). 2024 Nov 20;60(11):1905. doi: 10.3390/medicina60111905. Medicina (Kaunas). 2024. PMID: 39597090 Free PMC article.
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.
Lucijanic M, Krecak I, Galusic D, Holik H, Perisa V, Moric Peric M, Zekanovic I, Budimir J, Lekovic D, Kusec R. Lucijanic M, et al. Among authors: holik h. Ann Hematol. 2024 Jun;103(6):2157-2159. doi: 10.1007/s00277-024-05751-7. Epub 2024 Apr 23. Ann Hematol. 2024. PMID: 38652241 No abstract available.
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.
Aurer I, Jakšić O, Bašić-Kinda S, Mrđenović S, Ostojić-Kolonić S, Lozić D, Holik H, Novaković-Coha S, Berneš P, Krečak I, Morić-Perić M, Narančić M, Mitrović Z, Valković T. Aurer I, et al. Among authors: holik h. Biomedicines. 2024 Jan 31;12(2):331. doi: 10.3390/biomedicines12020331. Biomedicines. 2024. PMID: 38397933 Free PMC article.
47 results